Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer

Introduction. There has been a recent trend toward a gradual increase in the incidence of rectal cancer and a decrease in the average age of patients. These changes interpret the need to personalize treatment in each case.Objective – to evaluate the association of polymorphic variants of some genes...

Full description

Saved in:
Bibliographic Details
Main Authors: V. A. Grigorenko, E. P. Kulikov, S. A. Mertsalov, Yu. D. Kaminsky, A. A. Nikiforov, A. I. Sudakov
Format: Article
Language:Russian
Published: ABV-press 2021-07-01
Series:Успехи молекулярной онкологии
Subjects:
Online Access:https://umo.abvpress.ru/jour/article/view/355
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839573432189059072
author V. A. Grigorenko
E. P. Kulikov
S. A. Mertsalov
Yu. D. Kaminsky
A. A. Nikiforov
A. I. Sudakov
author_facet V. A. Grigorenko
E. P. Kulikov
S. A. Mertsalov
Yu. D. Kaminsky
A. A. Nikiforov
A. I. Sudakov
author_sort V. A. Grigorenko
collection DOAJ
description Introduction. There has been a recent trend toward a gradual increase in the incidence of rectal cancer and a decrease in the average age of patients. These changes interpret the need to personalize treatment in each case.Objective – to evaluate the association of polymorphic variants of some genes with the results of neoadjuvant chemoradiotherapy of rectal cancer.Materials and methods. We analyzed polymorphic variants of MTHFR, XPD, XRCC1, XRCC1, P53, VEGF, EGFR, TNF, CHEK2 and MMP1 genes in 76 patients with rectal cancer who underwent preoperative chemoradiation therapy followed by surgical treatment. Genotyping was performed by DNA isolation from venous blood leukocytes of the subjects followed by polymerase chain reaction with electrophoretic detection of the result.Results. Statistical analysis of the association of polymorphic variants of the studied genes with the treatment pathomorphosis revealed significance in relation to the MMP1-1607 gene (1G >2G) (p = 0.033). There was also an association of co-carrying polymorphic variants of TNF (G / A) + MMP1 (2G / 2G) genes with grade III–IV therapeutic pathomorphosis (p = 0.007).Conclusion. Carriage of recessive allele of MMP1 gene can be a predictor of favorable prognosis of preoperative chemoradiotherapy in patients with rectal cancer.
format Article
id doaj-art-d33b4764d16345e6b6b32b85d91004a5
institution Matheson Library
issn 2313-805X
2413-3787
language Russian
publishDate 2021-07-01
publisher ABV-press
record_format Article
series Успехи молекулярной онкологии
spelling doaj-art-d33b4764d16345e6b6b32b85d91004a52025-08-04T14:04:36ZrusABV-pressУспехи молекулярной онкологии2313-805X2413-37872021-07-0182475110.17650/2313-805X-2021-8-2-47-51210Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancerV. A. Grigorenko0E. P. Kulikov1S. A. Mertsalov2Yu. D. Kaminsky3A. A. Nikiforov4A. I. Sudakov5I. P. Pavlov Ryazan State Medical University, Ministry of Health of RussiaI. P. Pavlov Ryazan State Medical University, Ministry of Health of RussiaI. P. Pavlov Ryazan State Medical University, Ministry of Health of RussiaI. P. Pavlov Ryazan State Medical University, Ministry of Health of RussiaI. P. Pavlov Ryazan State Medical University, Ministry of Health of RussiaI. P. Pavlov Ryazan State Medical University, Ministry of Health of RussiaIntroduction. There has been a recent trend toward a gradual increase in the incidence of rectal cancer and a decrease in the average age of patients. These changes interpret the need to personalize treatment in each case.Objective – to evaluate the association of polymorphic variants of some genes with the results of neoadjuvant chemoradiotherapy of rectal cancer.Materials and methods. We analyzed polymorphic variants of MTHFR, XPD, XRCC1, XRCC1, P53, VEGF, EGFR, TNF, CHEK2 and MMP1 genes in 76 patients with rectal cancer who underwent preoperative chemoradiation therapy followed by surgical treatment. Genotyping was performed by DNA isolation from venous blood leukocytes of the subjects followed by polymerase chain reaction with electrophoretic detection of the result.Results. Statistical analysis of the association of polymorphic variants of the studied genes with the treatment pathomorphosis revealed significance in relation to the MMP1-1607 gene (1G >2G) (p = 0.033). There was also an association of co-carrying polymorphic variants of TNF (G / A) + MMP1 (2G / 2G) genes with grade III–IV therapeutic pathomorphosis (p = 0.007).Conclusion. Carriage of recessive allele of MMP1 gene can be a predictor of favorable prognosis of preoperative chemoradiotherapy in patients with rectal cancer.https://umo.abvpress.ru/jour/article/view/355rectal cancergene polymorphismcolorectal cancerneoadjuvant chemoradiotherapy
spellingShingle V. A. Grigorenko
E. P. Kulikov
S. A. Mertsalov
Yu. D. Kaminsky
A. A. Nikiforov
A. I. Sudakov
Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
Успехи молекулярной онкологии
rectal cancer
gene polymorphism
colorectal cancer
neoadjuvant chemoradiotherapy
title Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
title_full Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
title_fullStr Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
title_full_unstemmed Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
title_short Genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
title_sort genetic prognostic factors for neoadjuvant chemoradiotherapy for colorectal cancer
topic rectal cancer
gene polymorphism
colorectal cancer
neoadjuvant chemoradiotherapy
url https://umo.abvpress.ru/jour/article/view/355
work_keys_str_mv AT vagrigorenko geneticprognosticfactorsforneoadjuvantchemoradiotherapyforcolorectalcancer
AT epkulikov geneticprognosticfactorsforneoadjuvantchemoradiotherapyforcolorectalcancer
AT samertsalov geneticprognosticfactorsforneoadjuvantchemoradiotherapyforcolorectalcancer
AT yudkaminsky geneticprognosticfactorsforneoadjuvantchemoradiotherapyforcolorectalcancer
AT aanikiforov geneticprognosticfactorsforneoadjuvantchemoradiotherapyforcolorectalcancer
AT aisudakov geneticprognosticfactorsforneoadjuvantchemoradiotherapyforcolorectalcancer